DRI-ecstasy plus mdma/MDA reagent

Ended Awarded

Contract number
N6854623F6011
Awardee
Awarding agency
Obligated
$5,618

Award facts

Contract value 100% obligated
$5,618.20 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded a $5,618.20 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. Microgenics Corporation, a division of Thermo Electron Corporation, will deliver the requested MDMA/MDA testing reagents to the Navy's medical facility in Fremont, California by the January 11, 2023 completion date. No set-aside designation was used for this small purchase order to support the Bureau's drug testing programs. The reagents will allow the medical center laboratory to screen for the controlled substances MDMA and MDA.

Quick answers

Who was awarded contract N6854623F6011?

N6854623F6011 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on January 4, 2023.

How much is contract N6854623F6011 worth?

The government has obligated $5,618 on N6854623F6011.

Is contract N6854623F6011 an order under another contract?

Yes. N6854623F6011 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854623F6011 competed?

The extent of competition for N6854623F6011 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award